JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the pricing of $822,000 Callable Contingent Interest Notes linked to the performance of the Nasdaq-100 Technology Sector IndexSM, the S&P 500 Index, and the VanEck Oil Services ETF. The notes, which are unsecured and unsubordinated obligations of JPMorgan Financial, are fully and unconditionally guaranteed by JPMorgan Chase & Co. They are designed for investors seeking a Contingent Interest Payment for each Review Date where the closing value of each underlying is above 70% of its Initial Value, known as an Interest Barrier. The notes may be redeemed early at JPMorgan's discretion on specified Interest Payment Dates, with the earliest possible redemption date being October 29, 2024. The notes are...Show More

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the pricing of $822,000 Callable Contingent Interest Notes linked to the performance of the Nasdaq-100 Technology Sector IndexSM, the S&P 500 Index, and the VanEck Oil Services ETF. The notes, which are unsecured and unsubordinated obligations of JPMorgan Financial, are fully and unconditionally guaranteed by JPMorgan Chase & Co. They are designed for investors seeking a Contingent Interest Payment for each Review Date where the closing value of each underlying is above 70% of its Initial Value, known as an Interest Barrier. The notes may be redeemed early at JPMorgan's discretion on specified Interest Payment Dates, with the earliest possible redemption date being October 29, 2024. The notes are set to mature on June 29, 2026, and were priced on July 24, 2024, with an expected settlement date around July 29, 2024. The notes are linked to the individual performance of each underlying, rather than a combined basket, and investors should be willing to accept the risk of losing their principal and the possibility of receiving no Contingent Interest Payments. The notes are not bank deposits, are not FDIC insured, and involve a number of risks detailed in the accompanying prospectus supplement and product supplement.